Chelates and complexes for reduction in alcohol dependency
AssigneeAlbion International, Inc.
InventorsH. DeWayne Ashmead, R. Charles Thompson
Life of this patent
Estimating the term…
Abstract
A method for reducing alcohol desire or dependency in a human can comprise the steps of administering a chelate or a combination of chelates to a human having alcohol dependency symptoms or an unwanted desire for alcohol. Ligands that can be used include carnitine, naturally occurring amino acids, and various thiamine molecules. Metals that can be used include nutritionally relevant metals, including copper, zinc, and manganese, to name a few.
Claims48
A method for reducing alcohol desire or dependency, comprising the steps of:
- administering a therapeutically effective amount of an amino acid chelate to a human having symptoms of alcohol desire or dependency, said amino acid chelate comprising a naturally occurring amino acid ligand and a metal selected from the group consisting of copper, zinc, and manganese, and wherein the amino acid to metal molar ratio is from 1:1 to 4:1.
A method for reducing alcohol desire or dependency, comprising the steps of:
- administering a therapeutically effective amount of a composition to a human having symptoms of alcohol desire or dependency, said composition comprising a naturally occurring amino acid chelated to a nutritionally relevant metal, said composition further comprising thiamine complexed to the nutritionally relevant metal.
A method for reducing alcohol desire or dependency, comprising the steps of:
- administering a therapeutically effective amount of a metal carnitine chelate to a human having symptoms of alcohol desire or dependency, said metal carnitine chelate comprising a metal selected from the group consisting of copper, zinc, or manganese, and wherein the carnitine to metal molar ratio is from 1:1 to 2:1.
A method for reducing alcohol desire or dependency, comprising the steps of:
- administering a therapeutically effective amount of a metal thiamine chelate to a human having symptoms of alcohol desire or dependency, wherein the metal is chelated to thiamine through a π-cloud of an aromatic ring.
A composition for reducing alcohol dependency, comprising a metal carnitine chelate, said metal being selected from the group consisting of copper, zinc, or manganese, wherein the carnitine to metal molar ratio is from 1:1 to 2:1.
A thiamine-complexed metal amino acid chelate composition for reducing alcohol dependency, comprising a naturally occurring amino acid chelated to a nutritionally relevant metal, said composition further comprising thiamine complexed to the nutritionally relevant metal.
A composition for reducing alcohol dependency in humans, comprising a particulate blend of:
- a) a first amino acid chelate comprising a naturally occurring amino acid and a metal selected from the group consisting of copper, zinc, and manganese;
- and
- b) a second amino acid chelate comprising a second naturally occurring amino acid and
- a second metal selected from the group consisting of copper, zinc, and manganese,
- wherein the first amino acid chelate and the second amino acid chelate each having an amino acid to metal molar ratio from 1:1 to 4:1, and wherein the first amino acid chelate and the second amino acid chelate each have a different metal.
Dependencies are inferred from the claim text.